{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:52:16Z","timestamp":1790301136681,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0228315","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T13:25:04Z","timestamp":1581427504000},"page":"e0228315","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1707-9988","authenticated-orcid":true,"given":"Api","family":"Chewcharat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pol","family":"Chewcharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anawin","family":"Rutirapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Papatheodorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"issue":"6","key":"pone.0228315.ref001","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","article-title":"Update on Diabetic Nephropathy: Core Curriculum 2018. American journal of kidney diseases: the official journal of the","volume":"71","author":"K Umanath","year":"2018","journal-title":"National Kidney Foundation"},{"issue":"6865","key":"pone.0228315.ref002","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"P Zimmet","year":"2001","journal-title":"Nature"},{"issue":"10","key":"pone.0228315.ref003","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study","volume":"123","author":"JC Peterson","year":"1995","journal-title":"Annals of internal medicine"},{"issue":"2","key":"pone.0228315.ref004","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000084286","article-title":"Diabetic Nephropathy: The Proteinuria Hypothesis","volume":"25","author":"ME Williams","year":"2005","journal-title":"American Journal of Nephrology"},{"issue":"92","key":"pone.0228315.ref005","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1111\/j.1523-1755.2004.09222.x","article-title":"Detecting and managing patients with type 2 diabetic kidney disease: proteinuria and cardiovascular disease","author":"WE Mitch","year":"2004","journal-title":"Kidney Int Suppl"},{"issue":"14","key":"pone.0228315.ref006","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"HL Hillege","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"pone.0228315.ref007","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/STROKEAHA.110.581215","article-title":"Impact of microalbuminuria on incident stroke: a meta-analysis","volume":"41","author":"M Lee","year":"2010","journal-title":"Stroke"},{"issue":"9","key":"pone.0228315.ref008","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.2337\/dc08-0468","article-title":"High serum uric acid as a novel risk factor for type 2 diabetes: response to Dehghan","volume":"31","author":"G Lippi","year":"2008","journal-title":"Diabetes care"},{"issue":"1","key":"pone.0228315.ref009","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/rth2.12168","article-title":"Dietary intake of marine n-3 polyunsaturated fatty acids and future risk of venous thromboembolism","volume":"3","author":"T Isaksen","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"pone.0228315.ref010","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes: from molecules to man","volume":"45","author":"PC Calder","year":"2017","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"pone.0228315.ref011","doi-asserted-by":"crossref","first-page":"58","DOI":"10.6061\/clinics\/2017(01)10","article-title":"Omega-3 fatty acid supplementation as an adjunctive therapy in the treatment of chronic kidney disease: a meta-analysis","volume":"72","author":"J Hu","year":"2017","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"7","key":"pone.0228315.ref012","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/jcm6070070","article-title":"Omega-3 Polyunsaturated Fatty Acids for the Treatment of IgA Nephropathy","volume":"6","author":"J. Hirahashi","year":"2017","journal-title":"J Clin Med"},{"key":"pone.0228315.ref013","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12937-015-0068-2","article-title":"Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus","volume":"14","author":"C Arriens","year":"2015","journal-title":"Nutr J"},{"issue":"11","key":"pone.0228315.ref014","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1007\/s00296-013-2811-3","article-title":"Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus","volume":"33","author":"KJ Bello","year":"2013","journal-title":"Rheumatol Int"},{"key":"pone.0228315.ref015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cofs.2014.12.007","article-title":"Evaluating the therapeutic value of omega-3 polyunsaturated fatty acid supplementation on polycystic kidney disease and co-morbidities","volume":"2","author":"JC Tou","year":"2015","journal-title":"Current Opinion in Food Science"},{"issue":"7","key":"pone.0228315.ref016","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006020","article-title":"Omega-3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk","volume":"6","author":"SD Navaneethan","year":"2017","journal-title":"Journal of the American Heart Association"},{"issue":"6","key":"pone.0228315.ref017","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3945\/ajcn.2008.26867","article-title":"The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials","volume":"89","author":"ER Miller","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"pone.0228315.ref018","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS medicine"},{"key":"pone.0228315.ref019","first-page":"l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"JAC Sterne","year":"2019","journal-title":"BMJ (Clinical research ed)"},{"issue":"3","key":"pone.0228315.ref020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Controlled clinical trials"},{"issue":"7414","key":"pone.0228315.ref021","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ (Clinical research ed)"},{"issue":"8746","key":"pone.0228315.ref022","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0140-6736(91)90201-Y","article-title":"Publication bias in clinical research","volume":"337","author":"PJ Easterbrook","year":"1991","journal-title":"Lancet (London, England)"},{"issue":"7","key":"pone.0228315.ref023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004740","article-title":"Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease","volume":"6","author":"TK Elajami","year":"2017","journal-title":"Journal of the American Heart Association"},{"issue":"6","key":"pone.0228315.ref024","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/dc12-1940","article-title":"The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trial","volume":"36","author":"ER Miller","year":"2013","journal-title":"Diabetes care"},{"issue":"23","key":"pone.0228315.ref025","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJM198912073212304","article-title":"Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria","volume":"321","author":"T Jensen","year":"1989","journal-title":"The New England journal of medicine"},{"issue":"6","key":"pone.0228315.ref026","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0049-3848(86)90101-5","article-title":"Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics","volume":"43","author":"AP Haines","year":"1986","journal-title":"Thromb Res"},{"issue":"6","key":"pone.0228315.ref027","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jnutbio.2005.08.007","article-title":"N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination","volume":"17","author":"M Zeman","year":"2006","journal-title":"J Nutr Biochem"},{"issue":"1","key":"pone.0228315.ref028","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0168-8227(95)01056-J","article-title":"Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients","volume":"28","author":"H Shimizu","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"pone.0228315.ref029","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/diacare.19.11.1214","article-title":"Fish oil in diabetic nephropathy","volume":"19","author":"P Rossing","year":"1996","journal-title":"Diabetes care"},{"key":"pone.0228315.ref030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1749-6632.1997.tb51848.x","article-title":"Evaluation of an omega-3 fatty acid supplement in diabetics with microalbuminuria","volume":"827","author":"YK Lungershausen","year":"1997","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"pone.0228315.ref031","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF02537161","article-title":"Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester","volume":"25","author":"T Hamazaki","year":"1990","journal-title":"Lipids"},{"key":"pone.0228315.ref032","first-page":"208121","article-title":"Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy","volume":"2015","author":"SM Lee","year":"2015","journal-title":"International journal of endocrinology"},{"issue":"1","key":"pone.0228315.ref033","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ki.1993.215","article-title":"Fish oil in lupus nephritis: clinical findings and methodological implications","volume":"44","author":"WF Clark","year":"1993","journal-title":"Kidney international"},{"issue":"4","key":"pone.0228315.ref034","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.2040-1124.2011.00131.x","article-title":"Pathogenesis of diabetic nephropathy","volume":"2","author":"Z Cao","year":"2011","journal-title":"Journal of diabetes investigation"},{"key":"pone.0228315.ref035","doi-asserted-by":"crossref","first-page":"697010","DOI":"10.1155\/2015\/697010","article-title":"Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets","volume":"2015","author":"S Toth-Manikowski","year":"2015","journal-title":"J Diabetes Res"},{"issue":"1","key":"pone.0228315.ref036","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic Nephropathy: Diagnosis, Prevention, and Treatment","volume":"28","author":"JL Gross","year":"2005","journal-title":"Diabetes care"},{"issue":"23","key":"pone.0228315.ref037","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa021835","article-title":"Regression of microalbuminuria in type 1 diabetes","volume":"348","author":"BA Perkins","year":"2003","journal-title":"The New England journal of medicine"},{"issue":"12","key":"pone.0228315.ref038","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.2337\/dc16-0950","article-title":"Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes","volume":"39","author":"J Skupien","year":"2016","journal-title":"Diabetes care"},{"issue":"1","key":"pone.0228315.ref039","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12933-018-0740-x","article-title":"Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials","volume":"17","author":"LL O'Mahoney","year":"2018","journal-title":"Cardiovascular diabetology"},{"issue":"3","key":"pone.0228315.ref040","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1017\/S0007114512002036","article-title":"Association of fish and n-3 fatty acid intake with the risk of type 2 diabetes: a meta-analysis of prospective studies","volume":"108","author":"Y Zhou","year":"2012","journal-title":"The British journal of nutrition"},{"issue":"10","key":"pone.0228315.ref041","doi-asserted-by":"crossref","first-page":"e0139565","DOI":"10.1371\/journal.pone.0139565","article-title":"Effects of Omega-3 Fatty Acid Supplementation on Glucose Control and Lipid Levels in Type 2 Diabetes: A Meta-Analysis","volume":"10","author":"C Chen","year":"2015","journal-title":"PloS one"},{"issue":"12","key":"pone.0228315.ref042","first-page":"e673","article-title":"Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association","volume":"140","author":"AC Skulas-Ray","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"pone.0228315.ref043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3945\/an.111.000893","article-title":"Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life","volume":"3","author":"D Swanson","year":"2012","journal-title":"Advances in Nutrition"},{"key":"pone.0228315.ref044","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fnagi.2015.00052","article-title":"Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA","volume":"7","author":"SC Dyall","year":"2015","journal-title":"Front Aging Neurosci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T13:26:07Z","timestamp":1581427567000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228315"}},"subtitle":[],"editor":[{"given":"Tomislav","family":"Bulum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0228315","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]}}}